AL
MRK icon

Aspiriant LLC’s Merck MRK Stock Holding History

Aspiriant LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26M Buy
17,559
+2,125
+14% +$249K 0.06% 107
2026
Q1 		$1.86M Buy
15,434
+251
+2% +$29K 0.05% 116
2025
Q4 		$1.6M Buy
15,183
+1,373
+10% +$129K 0.05% 130
2025
Q3 		$1.16M Sell
13,810
-2,980
-18% -$245K 0.04% 137
2025
Q2 		$1.33M Buy
16,790
+1,696
+11% +$135K 0.04% 129
2025
Q1 		$1.35M Sell
15,094
-178
-1% -$16.6K 0.05% 120
2024
Q4 		$1.52M Sell
15,272
-105
-0.7% -$10.8K 0.05% 116
2024
Q3 		$1.75M Sell
15,377
-535
-3% -$63.6K 0.07% 102
2024
Q2 		$1.97M Sell
15,912
-3,269
-17% -$421K 0.08% 92
2024
Q1 		$2.53M Buy
19,181
+755
+4% +$93.1K 0.1% 87
2023
Q4 		$2.01M Buy
18,426
+161
+0.9% +$16.7K 0.09% 93
2023
Q3 		$1.88M Buy
18,265
+1,380
+8% +$149K 0.1% 93
2023
Q2 		$1.95M Sell
16,885
-95
-0.6% -$10.8K 0.1% 93
2023
Q1 		$1.81M Buy
16,980
+180
+1% +$19.4K 0.09% 93
2022
Q4 		$1.86M Sell
16,800
-194
-1% -$19.8K 0.1% 92
2022
Q3 		$1.46M Buy
16,994
+701
+4% +$62.6K 0.07% 97
2022
Q2 		$1.48M Sell
16,293
-456
-3% -$40.4K 0.07% 94
2022
Q1 		$1.37M Sell
16,749
-325
-2% -$25.6K 0.08% 107
2021
Q4 		$1.31M Buy
17,074
+2,446
+17% +$195K 0.07% 116
2021
Q3 		$1.1M Sell
14,628
-181
-1% -$13.8K 0.06% 112
2021
Q2 		$1.15M Sell
14,809
-430
-3% -$32K 0.07% 106
2021
Q1 		$1.12M Buy
15,239
+1,981
+15% +$146K 0.07% 95
2020
Q4 		$1.03M Sell
13,258
-31,086
-70% -$2.38M 0.07% 97
2020
Q3 		$3.51M Buy
44,344
+30,990
+232% +$2.43M 0.27% 44
2020
Q2 		$983K Sell
13,354
-1,443
-10% -$109K 0.09% 83
2020
Q1 		$1.08M Buy
14,797
+984
+7% +$77.3K 0.11% 77
2019
Q4 		$1.2M Sell
13,813
-478
-3% -$39.3K 0.11% 80
2019
Q3 		$1.15M Sell
14,291
-158
-1% -$12.7K 0.1% 92
2019
Q2 		$1.16M Sell
14,449
-929
-6% -$71.1K 0.1% 97
2019
Q1 		$1.22M Sell
15,378
-5,110
-25% -$382K 0.1% 99
2018
Q4 		$1.49M Sell
20,488
-1,119
-5% -$79K 0.11% 92
2018
Q3 		$1.46M Sell
21,607
-1,761
-8% -$112K 0.13% 93
2018
Q2 		$1.35M Buy
23,368
+1,155
+5% +$65.2K 0.12% 93
2018
Q1 		$1.16M Buy
+22,213
New +$1.2M 0.1% 96
2017
Q4 		– Sell
-21,317
Closed -$1.3M – 139
2017
Q3 		$1.3M Sell
21,317
-1,358
-6% -$82.3K 0.11% 94
2017
Q2 		$1.39M Sell
22,675
-1,771
-7% -$108K 0.12% 93
2017
Q1 		$1.48M Buy
24,446
+153
+0.6% +$9.28K 0.13% 98
2016
Q4 		$1.36M Buy
24,293
+576
+2% +$33.7K 0.12% 92
2016
Q3 		$1.41M Buy
23,717
+645
+3% +$37.7K 0.14% 86
2016
Q2 		$1.25M Sell
23,072
-1,315
-5% -$70K 0.12% 96
2016
Q1 		$1.23M Buy
+24,387
New +$1.19M 0.12% 92

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aspiriant LLC's MRK Position: Q2 2026 in Review

Aspiriant LLC increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $249K and bringing the position to 17,559 shares worth $2.26M. The position accounts for 0.06% of the portfolio, ranked #107.

Aspiriant LLC first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.51M in Q3 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspiriant LLC held 17,559 shares of Merck worth $2.26M as of Q2 2026.
  • Aspiriant LLC bought 2,125 Merck shares in Q2 2026, an estimated $249K.
  • Merck made up 0.06% of Aspiriant LLC's portfolio in Q2 2026, its #107 holding.
  • Aspiriant LLC first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
  • Aspiriant LLC's Merck position peaked at $3.51M in Q3 2020.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.